Buy Metonitazene-d3 CRM | Deuterated Opioid 100 µg

$155.82

7 products sold in last 16 hours

Selling fast! Over 13 people have in their cart

Metonitazene-d3 is a deuterated certified reference material (CRM) used as an internal standard in forensic, analytical, and toxicological research. It is specifically designed for accurate quantification and method validation of nitazene-class synthetic opioids. Supplied as a 100 µg CRM with documented purity and traceability, Metonitazene-d3 is suitable for high-precision LC-MS/MS and GC-MS applications. Intended strictly for research and analytical use by qualified professionals.

26 people are viewing this right now

Estimated Delivery : Up to 4 business days
Free Shipping & Returns : On all orders over $200

Guaranteed Safe And Secure Checkout

Metonitazene-d3 CRM – 100 µg

Metonitazene-d3 (CRM) is intended for use as an internal standard for the quantification of metonitazene by GC- or LC-MS. Metonitazene is categorized as an opioid.1 It has analgesic effects in mice.2 Metonitazene-d3 is regulated as a Schedule I compound in the United States. Metonitazene-d3 (CRM) (Item No. 43174) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

Formal Name: N,N-diethyl-2-[(4-methoxy-d3-phenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine
Molecular Formula: C21H23D3N4O3
Formula Weight: 385.5
Formulation: A 100 µg/ml solution in methanol
SMILES: CCN(CC)CCN1C(CC2=CC=C(OC([2H])([2H])[2H])C=C2)=NC3=CC([N+]([O-])=O)=CC=C31
InChi Code: InChI=1S/C21H26N4O3/c1-4-23(5-2)12-13-24-20-11-8-17(25(26)27)15-19(20)22-21(24)14-16-6-9-18(28-3)10-7-16/h6-11,15H,4-5,12-14H2,1-3H3/i3D3
InChi Key: HNGZTLMRQTVPBH-HPRDVNIFSA-N

Regulatory Information

DEA Exempt Notification: This product is a DEA exempt preparation of a scheduled compound – does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.